Adage Capital Partners Gp, L.L.C. Ovid Therapeutics Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $56.4 Billion
- Q2 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 1,150,000 shares of OVID stock, worth $632,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,150,000
Previous 1,150,000
-0.0%
Holding current value
$632,500
Previous $356,000
6.46%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding OVID
# of Institutions
71Shares Held
32.7MCall Options Held
15.6KPut Options Held
0-
Black Rock Inc. New York, NY3.99MShares$2.2 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$2.12 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.64MShares$1.45 Million0.0% of portfolio
-
Sio Capital Management, LLC New York, NY2.23MShares$1.23 Million0.35% of portfolio
-
Acadian Asset Management LLC Boston, MA2.11MShares$1.16 Million0.0% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $38.7M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...